C-Reactive Protein/Albumin Ratio and Acne Vulgaris

Ataturk University

Status: Completed

Conditions: Acne Vulgaris

Treatments: Diagnostic Test: Biochemical blood analysis

Study type: Observational

Funder types: Other

Identifiers

NCT06004583

30.12.2021/567

Details and patient eligibility

About

Objective: Acne vulgaris, an inflammatory disease, was investigated in this study with the claim that C-reactive protein (CRP) / albumin ratio and some hematological parameter ratios have the potential to be used as inflammatory markers to monitor disease severity and prognosis.

Methods: A descriptive cross-sectional study was conducted with two groups of patients aged 18-65 years, 61 patients diagnosed with acne vulgaris and 35 healthy control patients, and routine hemogram and biochemical parameters were compared. The Global Acne Severity Index was used to determine the severity of acne vulgaris.

Enrollment: 96 patients

Sex: All

Ages: 18 to 40 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Acne vulgaris patients diagnosed by a dermatologist
• Healthy participants without acne
• 18-40 years of age
• Voluntary participation

Exclusion criteria

• Aged below18 or above 40 years
• Not voluntarily participated patents
• Pregnants, breast milked mothers, emergency situations

Trial design

96 participants in 2 patient groups

Acne group

Description:

Acne Vulgaris Diagnosed Patients

Treatment:

Diagnostic Test: Biochemical blood analysis

Control group

Description:

Healthy participants

Treatment:

Diagnostic Test: Biochemical blood analysis